February 3rd, 2008 marks 12 months after getting the CT scan results confirming metastasis of my cervical cancer to my lungs (stage 4B). At that time my oncologist gave me 4-9 months survival even with chemotherapy (palliative only), and advised me to get my affairs in order. My cervical cancer is not responsive to any known conventional chemotherapy agents and metastatic cancer is a certain death sentance.
Not having any conventional treatment hopes, I went unconventional, since the unknown (unconventional, “unproven” treatments per FDA) is preferable to the known (FDA approved chemotherapy for metastatic cervical cancer guaranteed not to work) and started LDN 4.5 mg nightly on Feb 12, 2007.
From my latest CT scan (Jan 15, 2008), LDN has slowed the Doubling Time of the largest identified CA lung nodule to 225 days (when calculated from previous scan) versus the rate on Feb 3, 2007 of 33 days.
If the Doubling Time had remained unchanged (cancerous nodule doubling in size every 33 days), then the oncologist’s calculation of 9 months would have been accurate as largest nodule would have been near 9 cm in size by Nov 1st 2007, and conventionally accepted as the point where death will occur.
With the extra time that LDN has given me, my objective is to try out different complementary regimens, which will not conflict with LDN (the immune system modulator) and try to target the cancer cells more directly. LDN has proven, in my case, it’s ability to control the growth rate of my cancer so LDN will be the foundation on which I will add other treatments.
The first treatment I added to my daily LDN regimen was a high pH supplement. On Nov 13th, I started taking Cesium Chloride (CsCl) orally, approximately 6 grams per day, ingesting 96 grams total over a 30 day period (finished on Dec 13, 2007).
I waited 30 days and on January 15, 2008 started on the Artemisinin (ART) protocol as recommended by Dr. Singh, one of the early promoters of ART and a complementary treatment that Dr. Bihari had also tried when he was still practicing.
For my lung cancer, ART sounds like a more targeted protocol than CsCl because ART enters the bloodstream and cells which are high in iron content (characteristics of cancer cells) are the ones which will attract the ART, leaving normal cells more or less untouched. ART has been demonstrated as being toxic to some cancer cell lines (cervical is in the list) but as with other treatments (e.g. toxic chemo), getting the cancer cells to identify themselves is the holy grail.
My ART treatment is currently underway and I will know if there is any benefit at the next CT scan planned for April 2008.
Dee
